Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,148
datasets available to search
ShareScore release 0.9.0
Dataset results
2,148 results for “HER2”
Efficacy Study of Herceptin to Treat HER2-negative CTC Breast Cancer
ClinicalTrials.gov study NCT01548677. IPD Sharing: Not stated. Countries: 4. Publications: 1.
[68Ga]Ga-ABY-025 PET for Quantification of HER2-status in Solid Tumors
ClinicalTrials.gov study NCT05619016. IPD Sharing: NO. Countries: 1. Publications: 9.
TAC Versus TCX as Adjuvant Treatment for High-risk Her2-Negative Breast Cancer
ClinicalTrials.gov study NCT01354522. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Interest of the Addition of Docetaxel to Standard Treatment in First-line Advanced HER2 Positive Gastroesophageal Adenocarcinoma in Selective Patients
ClinicalTrials.gov study NCT04920747. IPD Sharing: NO. Countries: 1. Publications: 1.
Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations
ClinicalTrials.gov study NCT06581432. IPD Sharing: YES. Countries: 16. Publications: 0.
T-VEC With Chemotherapy or Endocrine Therapy in Treating Participants With HER2- Negative Breast Cancer
ClinicalTrials.gov study NCT03554044. IPD Sharing: NO. Countries: 1. Publications: 1.
Efficacy and Safety of Pyrotinib in HER2 Positive Gastrointestinal Tumors
ClinicalTrials.gov study NCT04960943. IPD Sharing: NO. Countries: 1. Publications: 1.
TAS102 in Patients With ER-positive, HER2-negative Advanced Breast Cancer
ClinicalTrials.gov study NCT04489173. IPD Sharing: NO. Countries: 1. Publications: 1.
Trastuzumab(Henlius®) Combined With Pertuzumab(Perjeta®) and Chemotherapy in Chinese Patients With Her2-Positive Metastatic Breast Cancer Previously Treated With Trastuzumab
ClinicalTrials.gov study NCT05188495. IPD Sharing: NO. Countries: 1. Publications: 1.
Study of Ramucirumab, Trastuzumab and Paclitaxel in Patients With HER2-positive Recurrent/Metastatic Gastric Cancer (HER-RAM Study)
ClinicalTrials.gov study NCT04888663. IPD Sharing: NO. Countries: 1. Publications: 1.
Phase II Study of T-DX in HER2-positive Breast Cancer Brain Metastases
ClinicalTrials.gov study NCT04752059. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Trial of BKM120/Tamoxifen-combination in Patients With HR-pos, HER2-neg Breast Cancer
ClinicalTrials.gov study NCT02404844. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Safety and Efficacy of BKM120 and Lapatinib in HER2+/PI3K-activated, Trastuzumab-resistant Advanced Breast Cancer
ClinicalTrials.gov study NCT01589861. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Famitinib Plus SHR6390 and Endocrine Therapy in the Treatment of HR-positive, HER2-negative Advanced Breast Cancer
ClinicalTrials.gov study NCT05176080. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PLD-cyclophosphamide-Nab-P Continuously Combined With Dual HER2 Blockage for HER2-positive Breast Cancer
ClinicalTrials.gov study NCT05346107. IPD Sharing: NO. Countries: 1. Publications: 1.
Study of Pyrotinib in Patients With Human Epidermalgrowth Factor Receptor 2 (HER2) Positive Advanced Breast Cancer
ClinicalTrials.gov study NCT01937689. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Tumor-microenvironment Spatial Interaction to Identify Markers of Resistance to Therapy in HER2+ Breast Cancer Patients
ClinicalTrials.gov study NCT06518382. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Gemcitabine, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer After Prior Trastuzumab/Pertuzumab, or Pertuzumab Based Therapy
ClinicalTrials.gov study NCT02252887. IPD Sharing: Not stated. Countries: 1. Publications: 1.
TCH Versus EC-TH as Neoadjuvant Treatment for HER2-Positive Breast Cancer
ClinicalTrials.gov study NCT03140553. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Myocet + Cyclophosphamide + Metformin Vs Myocet + Cyclophosphamide in 1st Line Treatment of HER2 Neg. Metastatic Breast Cancer Patients
ClinicalTrials.gov study NCT01885013. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.